Related Experiment Video
Updated: Feb 4, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
Mutational scanning reveals oncogenic CTNNB1 mutations have diverse effects on signaling
Anagha Krishna1, Alison Meynert2, Karamjit Singh Dolt3
1The Roslin Institute, University of Edinburgh, Edinburgh, UK.
Abstract:
CTNNB1, the gene encoding β-catenin, is a frequent target for oncogenic mutations activating the canonical Wnt signaling pathway, typically through missense mutations within a degron hotspot motif in exon 3. Here, we combine saturation genome editing with a fluorescent reporter assay to quantify signaling phenotypes for all 342 possible missense mutations in the mutation hotspot. Our data define the genetic requirements for β-catenin degron function, refine the consensus motif for substrate recognition by β-TRCP and reveal diverse levels of signal activation among known driver mutations. Tumorigenesis in different human tissues involves selection for CTNNB1 mutations spanning distinct ranges of predicted activity. In hepatocellular carcinoma, mutation effect scores distinguish two tumor subclasses with different levels of β-catenin signaling, and weaker mutations predict greater immune cell infiltration in the tumor microenvironment. Our work provides a resource to understand mutational diversity within a pan-cancer mutation hotspot, with potential implications for targeted therapy.
Insights
This study maps all possible CTNNB1 mutations, revealing how they activate Wnt signaling. Findings clarify beta-catenin degron function and have implications for cancer therapy and understanding tumor microenvironments.
Area of Science:
- Molecular Biology
- Cancer Genomics
- Biochemistry
Background:
- CTNNB1 mutations activate the Wnt pathway, driving cancer.
- Missense mutations in exon 3 are common oncogenic drivers.
- Understanding these mutations is key for targeted cancer therapies.
Purpose of the Study:
- To systematically analyze all 342 possible missense mutations in the CTNNB1 degron hotspot.
- To quantify the signaling phenotypes associated with each mutation.
- To define the genetic basis of beta-catenin degron function and Wnt pathway activation.
Main Methods:
- Saturation genome editing coupled with a fluorescent reporter assay.
- Systematic mutagenesis of the CTNNB1 exon 3 hotspot.
- Analysis of mutation effect scores and correlation with tumor subclasses.
Main Results:
- Defined the functional requirements of the beta-catenin degron.
- Refined the consensus motif for beta-transducin repeat-containing protein (β-TRCP) recognition.
- Revealed diverse Wnt signaling activation levels for known driver mutations.
- Identified distinct mutation activity ranges selected in different human cancers.
- Linked mutation effect scores to distinct hepatocellular carcinoma subclasses and immune infiltration.
Conclusions:
- Provides a comprehensive resource for understanding CTNNB1 mutational diversity in cancer.
- Offers insights into the structure-function relationships of the beta-catenin degron.
- Suggests potential for developing targeted therapies based on mutation-specific Wnt signaling levels.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift
Mutations in Microorganisms
Point and Frameshift Mutations

